CLSA’s Sara Radcliffe at the Milken Institute’s 2015 Global Conference: Accelerating Medical Research: The Bipartisan Quest for Cures
On April 27, 2015, California Life Sciences Association (CLSA) President & CEO Sara Radcliffe participated in a panel discussion at the Milken Institute’s 2015 Global Conference in Los Angeles with Joe Barton, U.S. Congressman, Texas; Dr. Francis Collins, Director, National Institutes of Health; Robert Hugin, Chairman and CEO, Celgene; and Michael Milken, Chairman, Milken Institute to discuss maintaining and accelerating U.S. leadership in medical research and innovation. The panel was moderated by Margaret Anderson, Executive Director, FasterCures, a Center of the Milken Institute. View the discussion here or below.
About the Panel
For all their many differences, Washington pundits and politicians frequently find common ground in the search for better therapies for our most devastating diseases. A rare bright spot of comity and bipartisanship, this shared interest in maintaining U.S. leadership in medical innovation presents several opportunities in 2015. From the 21st Century Cures legislation in Congress to the president’s Precision Medicine Initiative to the FDA’s next round of user fee negotiations, legislative and regulatory calendars are filling up with chances to advance science and help patients. Will 2015 bring the policy fixes needed to lower drug costs and increase patient input in the healthcare system? What can patients expect from Washington in the months ahead?
Learn more at the Milken Institute.